8 January 2016 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International has appointed Howard Schiller as interim chief executive officer, while Michael Pearson remains on "medical leave of absence".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.